IL10 and acute graft versus host disease: Recipients of a graft carrying the -1082GG IL10 gene promoter region variant had a three-fold lower incidence of grade II–IV acute GVHD compared to IL10-1082AA graft recipients (SHR = 0.25, p = 0.005).